LICH AI

Lich is a Salt Lake City-based biotechnology company that utilizes artificial intelligence to redefine the drug discovery process. Founded by former leadership from Recursion Pharmaceuticals, the company focuses on building a scalable platform that integrates massive biological datasets with sophisticated machine learning models. By mapping the complexities of cellular biology, Lich aims to identify novel therapeutic targets and optimize the development of new medicines. The company's approach combines high-throughput experimental biology with advanced computational techniques to increase the efficiency and success rate of drug R&D. Lich is currently in the early stages of developing its internal pipeline and platform capabilities.